Abstract
OMIM: #261640, #233910, #261630, AND #264070
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Burgard P, Lachmann RH, Walter J (2016) Hyperphenylalaninaemia. In: Saudubray JM, Baumgartner MR, Walter J (eds) Inborn metabolic diseases: diagnosis and treatment. Springer, pp 251–263. https://doi.org/10.1007/978-3-662-49771-5_16
Danks DM, Bartholomé K, Clayton BE, Curtius H, Gröbe H, Kaufman S, Leeming R, Pfleiderer W, Rembold H, Rey F (1978) Malignant hyperphenylalaninaemia—current status (June 1977). J Inherit Metab Dis 1(2):49–53. https://doi.org/10.1007/BF01801843
Dhondt JL (1984) Tetrahydrobiopterin deficiencies: preliminary analysis from an international survey. J Pediatr 104(4):501–508. https://doi.org/10.1016/S0022-3476(84)80537-5
Kaufman S (1963) The structure of phenylalanine-hydroxylation cofactor. Proc Natl Acad Sci U S A 50(6):1085–1093. https://doi.org/10.1073/pnas.50.6.1085
Longhi R, Valsasina R, Buttè C, Paccanelli S, Riva E, Giovannini M (1985) Cranial computerized tomography in dihydropteridine reductase deficiency. J Inherit Metab Dis 8(3):109–112. https://doi.org/10.1007/BF01819291
Manti F, Nardecchia F, Banderali G, Burlina A, Carducci C, Carducci C, Donati MA, Gueralid D, Paci S, Pochiero F, Porta F, Ortolano R, Rovelli V, Schiaffino MC, Spada M, Blau N, Leuzzi V (2020) Long-term clinical outcome of 6-pyruvoyl-tetrahydropterin synthase-deficient patients. Mol Genet Metab 131(1–2):155–162. https://doi.org/10.1016/j.ymgme.2020.06.009
Niederwieser A, Curtius HC, Wang M, Leupold D (1982) Atypical phenylketonuria with defective biopterin metabolism. Monotherapy with tetrahydrobiopterin or sepiapterin, screening and study of biosynthesis in man. Eur J Pediatr 138(2):110–112. https://doi.org/10.1007/BF00441135
Opladen T, López-Laso E, Cortès-Saladefont E, Pearson TS, Sivri HS, Yildiz Y, Assmann B, Kurian MA, Leuzzi V, Heales S, Pope S, Porta F, García-Cazorla A, Honzík T, Pons R, Regal L, Goez H, Artuch R, Hoffmann GF, Horvath G, Thöny B, Scholl-Bürgi S, Burlina A, Verbeek MM, Mastrangelo M, Friedman J, Wassenberg T, Jeltsch K, Kulhánek J, Hübschmann OY, Internation Working Group on Neurotransmitter disorders (iNTD) (2020) Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies. Orphanet J Rare Dis 15(1):126. https://doi.org/10.1186/s13023-020-01379-8
Opladen T, Hoffmann GF, Blau N (2012) An international survey of patients with tetrahydrobiopterin deficiencies presenting with hyperphenylalaninaemia. J Inherit Metab Dis 35(6):963–973. https://doi.org/10.1007/s10545-012-9506-x
van Wegberg AMJ, MacDonald A, Ahring K, Bèlanger-Quintana A, Blau N, Bosch AM, Burlina A, Campistol J, Feillet F, Giżewska M, Hujibregts SC, Kearney S, Leuzzi V, Maillot F, Muntau AC, van Rijn M, Trefz F, Walter JH, van Spronsen FJ (2017) The complete European guidelines on phenylketonuria: diagnosis and treatment. Orphanet J Rare Dis 12:162. https://doi.org/10.1186/s13023-017-0685-2
Winn SR, Scherer T, Thöny B, Harding CO (2016) High dose sapropterin dihydrochloride therapy improves monoamine neurotransmitter turnover in murine phenylketonuria (PKU). Mol Genet Metab 117(1):5–11. https://doi.org/10.1016/j.ymgme.2015.11.012
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this entry
Cite this entry
Corado, A.M. (2023). Hyperphenylalaninemia, BH4 Deficient (HPABH4). In: Rezaei, N. (eds) Genetic Syndromes. Springer, Cham. https://doi.org/10.1007/978-3-319-66816-1_1759-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-66816-1_1759-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-66816-1
Online ISBN: 978-3-319-66816-1
eBook Packages: Springer Reference MedicineReference Module Medicine